Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 24897816)

1.

Cardiovascular prevention: lifestyle and statins--competitors or companions?

Opie LH, Dalby AJ.

S Afr Med J. 2014 Mar;104(3):168-73. Review.

PMID:
24897816
2.

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Postgrad Med J. 2008 Nov;84(997):590-8. doi: 10.1136/hrt.2007.125401. Review.

PMID:
19103817
4.
5.
6.

Dyslipidemia: management using optimal lipid-lowering therapy.

Ito MK.

Ann Pharmacother. 2012 Oct;46(10):1368-81. doi: 10.1345/aph.1R127. Epub 2012 Oct 2. Review.

PMID:
23032652
7.

Lipid-lowering therapy: who can benefit?

Lewis SJ.

Vasc Health Risk Manag. 2011;7:525-34. doi: 10.2147/VHRM.S23113. Epub 2011 Aug 24. Review.

8.

Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.

Pedersen TR.

Am J Cardiovasc Drugs. 2010;10 Suppl 1:10-7. doi: 10.2165/1158822-S0-000000000-00000. Review.

PMID:
21391729
9.

A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs.

Alla VM, Agrawal V, DeNazareth A, Mohiuddin S, Ravilla S, Rendell M.

Drugs. 2013 Jul;73(10):1025-54. doi: 10.1007/s40265-013-0072-9. Review.

PMID:
23754124
10.

Intensive statin therapy for Indians: Part-I. Benefits.

Enas EA, Pazhoor HC, Kuruvila A, Vijayaraghavan K.

Indian Heart J. 2011 May-Jun;63(3):211-27. Review.

PMID:
22734339
11.

Beyond the statins: new therapeutic perspectives in cardiovascular disease prevention.

Chapman MJ.

Cardiovasc Drugs Ther. 2005 Mar;19(2):135-9. Review.

PMID:
16025232
12.

Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?

Fabbri G, Maggioni AP.

Adv Ther. 2009 May;26(5):469-87. doi: 10.1007/s12325-009-0025-6. Epub 2009 May 14. Review.

PMID:
19444394
13.

Can a statin neutralize the cardiovascular risk of unhealthy dietary choices?

Ferenczi EA, Asaria P, Hughes AD, Chaturvedi N, Francis DP.

Am J Cardiol. 2010 Aug 15;106(4):587-92. doi: 10.1016/j.amjcard.2010.03.077.

PMID:
20691321
14.

Balanced pan-PPAR activator bezafibrate in combination with statin: comprehensive lipids control and diabetes prevention?

Tenenbaum A, Fisman EZ.

Cardiovasc Diabetol. 2012 Nov 14;11:140. doi: 10.1186/1475-2840-11-140. Review.

15.

Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.

Natsuaki M, Furukawa Y, Morimoto T, Nakagawa Y, Ono K, Kaburagi S, Inada T, Mitsuoka H, Taniguchi R, Nakano A, Kita T, Sakata R, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.

Circ J. 2012;76(6):1369-79. Epub 2012 Mar 15.

16.

Lipid management for the prevention of cardiovascular disease.

Schaefer JR.

Curr Pharm Des. 2011;17(9):852-60. Review.

PMID:
21418030
17.

New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes.

Sahebkar A, Watts GF.

Clin Ther. 2013 Aug;35(8):1082-98. doi: 10.1016/j.clinthera.2013.06.019. Epub 2013 Aug 8. Review.

PMID:
23932550
18.

Evidence-based use of statins for primary prevention of cardiovascular disease.

Minder CM, Blaha MJ, Horne A, Michos ED, Kaul S, Blumenthal RS.

Am J Med. 2012 May;125(5):440-6. doi: 10.1016/j.amjmed.2011.11.013. Epub 2012 Mar 2. Review.

PMID:
22387091
19.

Statins for the primary prevention of cardiovascular disease.

Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, Ward K, Ebrahim S.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD004816. doi: 10.1002/14651858.CD004816.pub5. Review.

PMID:
23440795
20.

A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive Cardiology.

Joshi PH, Chaudhari S, Blaha MJ, Jones SR, Martin SS, Post WS, Cannon CP, Fonarow GC, Wong ND, Amsterdam E, Hirshfeld JW, Blumenthal RS.

Clin Cardiol. 2012;35(7):404-9. doi: 10.1002/clc.22016. Epub 2012 Jun 6. Review.

PMID:
22674150
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk